BACKGROUND: The apolipoprotein E (APOE) ε4 allele has been implicated in a range of neuropsychiatric conditions. The present research examined if the ε4 allele of the APOE gene moderated the effect of combat exposure on posttraumatic stress disorder (PTSD) among Iraq/Afghanistan-era veterans. METHOD: Participants included 765 non-Hispanic White (NHW) and 859 non-Hispanic Black (NHB) Iraq/Afghanistan-era veterans. A structured interview established psychiatric diagnoses. Combat exposure and PTSD symptom severity were assessed via self-report. RESULTS: The most common lifetime diagnoses were depression (39.2%), PTSD (38.4%), and alcohol dependence (24.38%). After correcting for multiple comparisons, no significant effects were observed on any of the outcomes among the NHW sample; however, within the NHB sample, significant gene × environment (G × E) interactions were observed for lifetime PTSD (P = .0029) and PTSD symptom severity (P = .0009). In each case, the APOE ε4 allele had no effect on the outcomes when combat exposure was low; however, when combat exposure was high, an additive effect was observed such that ε4 homozygotes exposed to high levels of combat reported the highest rates of PTSD (92%) and the worst symptom severity scores on the Davidson Trauma Scale (M = 79.5). CONCLUSIONS: Although preliminary, these findings suggest that the APOE ε4 allele, in conjunction with exposure to high levels of combat exposure, may increase veterans' risk for developing PTSD.
BACKGROUND: The apolipoprotein E (APOE) ε4 allele has been implicated in a range of neuropsychiatric conditions. The present research examined if the ε4 allele of the APOE gene moderated the effect of combat exposure on posttraumatic stress disorder (PTSD) among Iraq/Afghanistan-era veterans. METHOD:Participants included 765 non-Hispanic White (NHW) and 859 non-Hispanic Black (NHB) Iraq/Afghanistan-era veterans. A structured interview established psychiatric diagnoses. Combat exposure and PTSD symptom severity were assessed via self-report. RESULTS: The most common lifetime diagnoses were depression (39.2%), PTSD (38.4%), and alcohol dependence (24.38%). After correcting for multiple comparisons, no significant effects were observed on any of the outcomes among the NHW sample; however, within the NHB sample, significant gene × environment (G × E) interactions were observed for lifetime PTSD (P = .0029) and PTSD symptom severity (P = .0009). In each case, the APOE ε4 allele had no effect on the outcomes when combat exposure was low; however, when combat exposure was high, an additive effect was observed such that ε4 homozygotes exposed to high levels of combat reported the highest rates of PTSD (92%) and the worst symptom severity scores on the Davidson Trauma Scale (M = 79.5). CONCLUSIONS: Although preliminary, these findings suggest that the APOE ε4 allele, in conjunction with exposure to high levels of combat exposure, may increase veterans' risk for developing PTSD.
Authors: E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance Journal: Science Date: 1993-08-13 Impact factor: 47.728
Authors: Thomas Freeman; Vincent Roca; Fred Guggenheim; Tim Kimbrell; W S T Griffin Journal: J Neuropsychiatry Clin Neurosci Date: 2005 Impact factor: 2.198
Authors: J R Davidson; S W Book; J T Colket; L A Tupler; S Roth; D David; M Hertzberg; T Mellman; J C Beckham; R D Smith; R M Davison; R Katz; M E Feldman Journal: Psychol Med Date: 1997-01 Impact factor: 7.723
Authors: Werner Koch; Angela Ehrenhaft; Korinna Griesser; Arne Pfeufer; Jakob Müller; Albert Schömig; Adnan Kastrati Journal: Clin Chem Lab Med Date: 2002-11 Impact factor: 3.694
Authors: Natalie P Mota; Shizhong Han; Ilan Harpaz-Rotem; Paul Maruff; John H Krystal; Steven M Southwick; Joel Gelernter; Robert H Pietrzak Journal: Depress Anxiety Date: 2017-11-24 Impact factor: 6.505
Authors: Nathan A Kimbrel; Melanie E Garrett; Michelle F Dennis; Yutao Liu; Ilyas Patanam; Va Mid-Atlantic Mirecc Workgroup; Allison E Ashley-Koch; Michael A Hauser; Jean C Beckham Journal: Psychiatry Res Date: 2015-07-08 Impact factor: 3.222
Authors: Victoria C Merritt; Alexandra L Clark; Scott F Sorg; Nicole D Evangelista; Madeleine Werhane; Mark W Bondi; Dawn M Schiehser; Lisa Delano-Wood Journal: J Neurotrauma Date: 2018-06-07 Impact factor: 5.269
Authors: Mira Brancu; H Ryan Wagner; Rajendra A Morey; Jean C Beckham; Patrick S Calhoun; Larry A Tupler; Christine E Marx; Katherine H Taber; Robin A Hurley; Jared Rowland; Scott D McDonald; Jeffrey M Hoerle; Scott D Moore; Harold S Kudler; Richard D Weiner; John A Fairbank Journal: Int J Methods Psychiatr Res Date: 2017-06-27 Impact factor: 4.035
Authors: Nathan A Kimbrel; Melanie E Garrett; Michelle F Dennis; Michael A Hauser; Allison E Ashley-Koch; Jean C Beckham Journal: Psychiatry Res Date: 2018-07-17 Impact factor: 3.222
Authors: Chandra A Reynolds; Margaret Gatz; Kaare Christensen; Lene Christiansen; Anna K Dahl Aslan; Jaakko Kaprio; Tellervo Korhonen; William S Kremen; Robert Krueger; Matt McGue; Jenae M Neiderhiser; Nancy L Pedersen Journal: Behav Genet Date: 2015-11-04 Impact factor: 2.805
Authors: Yutao Liu; Melanie E Garrett; Michelle F Dennis; Kimberly T Green; Allison E Ashley-Koch; Michael A Hauser; Jean C Beckham; Nathan A Kimbrel Journal: PLoS One Date: 2015-03-20 Impact factor: 3.240
Authors: Brandon Lucke Wold; Richard Nolan; Divine Nwafor; Linda Nguyen; Cletus Cheyuo; Ryan Turner; Charles Rosen; Robert Marsh Journal: J Neurosci Neuropharmacol Date: 2018-03-02